VATEL CAPITAL
Vatel Capital, founded in 2008 and based in Paris, is an independent and entrepreneurial asset management company specializing in financing and supporting French growth SMEs, both listed and unlisted, as well as investing in tangible assets like forests, agricultural land, and renewable energy. It manages over €550 million in assets and offers various investment solutions including FCPI, FIP, and funds focused on private debt and small caps.
VATEL CAPITAL is a Paris growth equity firm with €550M AUM, 14 active companies and 2 exits.
Sector breakdown
16 companiesKey facts
Recent exits
VATEL CAPITAL sold Zoomalia to Holding Nicole in 2025 after 6 years.
VATEL CAPITAL sold OHRE Pharma to Strategic Generics France in 2021 after 3 years.
Coverage notes
2 funds tracked, 16 portfolio companies (14 active · 2 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund VATEL CAPITAL has raised, with its portfolio companies. Hand-checked from public filings.
Vatel FlexibleharvestingEvergreen2021€80M12 assetsEvergreen2021 · 5yr€80M12–
Unrealized
12 held| Company | Entry |
|---|---|
| Bio Jag Healthcare · France | 2023 |
| Crossject Pharma · France | 2025 |
| Enogia Energy · France | 2025 |
| Entech ClimateTech · France | 2025 |
| Haffner Energy ClimateTech · France | 2025 |
| Hoffmann Green Cement ClimateTech · France | 2025 |
| Iznes Fintech · France | 2025 |
| Largo E-commerce · France | 2025 |
| Lexibook Consumer · France | 2024 |
| Median Technologies MedTech · France | 2025 |
| Mipise Industrials · France | 2022 |
| Odyssee Technologies Aerospace & Defence · France | 2024 |
Vatel CapitalharvestingEvergreen2018€50M2 assets2 exitsEvergreen2018 · 8yr€50M22
Unrealized
2 held| Company | Entry |
|---|---|
| Agripower Energy · France | 2019 |
| Fill Up Media TMT · France | 2017 |
Realized
2 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| OHRE Pharma Pharma · France | 2018 | 2021 | Trade Sale | Strategic Generics France | – |
| Zoomalia TMT · France | 2019 | 2025 | Trade Sale | Holding Nicole | – |
About VATEL CAPITAL
Vatel Capital is an independent and entrepreneurial asset management company with €550 million of assets under management, founded in 2008 and headquartered in Paris. The firm specialises in financing and supporting French growth SMEs (both listed and unlisted) with a multi-stage approach across the French SME ecosystem.
Investment thesis
Vatel Capital targets French growth SMEs across listed and unlisted segments, deploying growth equity and selective buyout commitments with equity tickets typically ranging from €5 million to €25 million per transaction. Sector focus spans TMT and selectively other French SME verticals, with the platform's hybrid listed/unlisted mandate distinguishing Vatel from pure private equity peers. The entrepreneurial heritage enables operational partnership with founder-operator management teams.
Recent activity
Recent realised exits include ZOOMALIA (TMT, 2025), reflecting selective distribution activity across the French SME portfolio. The platform tracks 3 funds, 7 active portfolio companies and 2 realised exits across the multi-vintage programme.
Frequently asked questions
- What investment strategy does VATEL CAPITAL focus on?
- VATEL CAPITAL focuses on Growth, Buyout strategies in the private equity space.
- How many portfolio companies does VATEL CAPITAL have?
- VATEL CAPITAL has 14 active portfolio companies and 2 completed exits and 2 funds tracked on GP Intel.
- Where is VATEL CAPITAL headquartered?
- VATEL CAPITAL is headquartered in Paris, France.
- What is VATEL CAPITAL's assets under management?
- VATEL CAPITAL manages approximately €550M in assets under management.
- When was VATEL CAPITAL founded?
- VATEL CAPITAL was founded in 2008.
- What sectors does VATEL CAPITAL invest in?
- VATEL CAPITAL invests across Healthcare, Energy, Business Services, Industrials.
- What are VATEL CAPITAL's recent exits?
- Recent realized exits by VATEL CAPITAL include: ZOOMALIA (2025) to Holding Nicole; OHRE Pharma (2021) to Strategic Generics France.
Similar firms
Other private equity firms tracked on GP Intel.